InsiderTrades

Manion Douglas J.

SEC CIK 1875875 · EDGAR

Buying vs selling by month open-market trades, last 43 months, ACRS
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ACRSAclaris Therapeutics, Inc.Pres, CEO, Dir 41.8K $99.8K — 62023-03-092024-01-01

Most active insiders at ACRS, 12 months

#InsiderTitleBoughtSold
1 Leonard Braden Michael10% —$1.36M
2 Kolbeck Roland WilhelmCSO ——
3 Hall Jesse WayneChief Medical Off ——
4 Davis Hugh M.Pres, COO, Dir ——
5 Balthaser KevinCFO ——
6 Loerop JamesChief Business Off ——
7 Humphries William D.Dir ——
8 Molineaux Christopher P.Dir ——
9 Walker NealCEO, Dir ——
10 Mehra AnandDir ——

Manion Douglas J. made no open-market trades at ACRS in the last 12 months.

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-03 2024-01-01 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir F - Tax $1.05 -9,125 41.8K -18% -$9,581
D 2024-01-03 2024-01-01 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir M - OptEx — +27.0K 50.9K +113% —
D 2023-08-03 2023-08-01 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir M - OptEx — +15.6K 28.4K +122% —
D 2023-08-03 2023-08-01 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir F - Tax $9.81 -4,437 23.9K -16% -$43.5K
2023-03-17 2023-03-17 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir P - Purchase $7.86 +6,300 12.8K +97% +$49.5K
2023-03-09 2023-03-09 ACRS Aclaris Therapeutics, Inc. Manion Douglas J. Pres, CEO, Dir P - Purchase $7.74 +6,500 6,500 New +$50.3K

Purchase Sale Sale after option exercise All abbreviations